Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I will say if there is any hope it's that some shares continue to trade. Perhaps enough to prevent FINRA from delisting ??
Omar, It's looking as if you're going to have to let it go. You're the last one that is expecting anything, well you and Bad Billy, how ironic.
No we don't have to deal with those who are complaining about the dismal performance of a stock on a MB, if you want to that's fine. But if you look at all that has not happen with this company as an investment, this crowd has plenty to complain about.
You proclaiming more potential then ever reminds me of the Black Night guarding the bridge.
There is a fine line of word trickery we see being walked everyday. Not only with a press release from any company, but also in any advertising. Use one word instead of the other is the difference between being liable or not.
The few times over the years that NNLX has tried to express hope of a viable idea you can't fault them for wanting to put stuff in a good light.
And some of see a forest when there are no trees.
Obviously the market doesn't invent or reinvent things, only evaluates them.
I suppose if NNLX could show something of value the PPS would be in keeping with that.
Why call NNLX, is it common for them to relay relevant business information that way?
How profound that was. No one can prove anything. So there is a CEO that said holly cow, the stock goes to .0002 and can't be bought. But there is this one guy on all the MBs that knows everyone doesn't see what he see's. What should I do?
Perhaps you could sell now at the .0001 bid? I doubt the order would fill.
If NNLX claims bankrupt your tax deduction would be automatic.
Don't act on what I say, ask your broker.
Sorry, reread and I think explanation is needed. I believe you are now in the position of not being able to sell your shares so you can't claim a loss. If bankruptcy is declared you don't have to sell, you lost.
Yes.
Yes, same shelf. You know I've been here all along, this has been a perfect example of a rule I learned to follow with this type of start of investing. When the idea that interested you doesn't work, move on. There has been a lot to learn here.
It's sitting on a shelf somewhere, deemed worthless.
All these years they've never shown they are even capable or aware of their fiduciary duties. Only thing that Bret has done is avoid bankruptcy for 14 years.
Just guessing the Forex market, and other Brokers you never heard of will allow buying, but other then small lots you haven't been able to sell anyway, there are no buyers. Basically you will be stuck with the hope that things are not as bad as they appear and NNLX will pull a rabbit out of the unseen hat, in which case there will be buyers. Same thing it has been for some time.
I don't know where NNLX is on this but I think "the neutralizing antibody to the virus is critical in determining the need for vaccination" should most definitely be in the public discussion, and it's not. This mandatory vaccination stuff isn't going to go over to well, maybe NNLX will save us.
Once again, thank you for doing this!
It's like they are preannouncing the end of the epidemic
This PCR story is not a new story, It's not like the "experts" haven't known and discussed the PCR faults since it's inception. My limited knowledge tells me it was used recklessly. Would think for diagnosing diseases a scientist would at least want to know the threshold count with a positive result. Florida has been reporting thresholds since Dec., I hope to someday see what that might reveal about the mysteries asymptomatic.
Quietly abandoning the test is best way for them, cause it don't look good.
There is no lack of perceived shortcomings, laugh if you want too.
I assumed at the time, and still do, it was a large company checking out NNLX claims, and that's what I'm talking about. If I had a research and development department with a healthy budget I would expect them to check out everything they hear about.
What happened to them? I assume they walked away.
"Please give us the names of companies that have walked away from nanologix"
AbbVie (NYSE:ABBV) $113.7 billion
Adaptive Biotechnologies (NASDAQ:ADPT) $3.4 billion
Alexion Pharmaceuticals (NASDAQ:ALXN) $21.7 billion
Alnylam Pharmaceuticals (NASDAQ:ALNY) $12.6 billion
Amgen (NASDAQ:AMGN) $122.9 billion
Bayer (OTC:BAYR.Y) $60.2 billion
Biogen (NASDAQ:BIIB) $54.1 billion
CSL Behring $89.8 billion
CytoDyn (NASDAQOTH:CYDY) $1.3 billion
Emergent BioSolutions (NYSE:EBS) $3.1 billion
Gilead Sciences (NASDAQ:GILD) $96.6 billion
Grifols (NASDAQ:GRFS) $19.5 billion
Incyte (NASDAQ:INCY) $18 billion
Eli Lilly (NYSE:LLY) $135.8 billion
Mesoblast (NASDAQ:MESO) $6.1 billion
Novartis (NYSE:NVS) $193.1 billion
Regeneron Pharmaceuticals (NASDAQ:REGN) $55.5 billion
Roche Holding (OTC:RHHBY) $286.7 billion
Sanofi $112.9 billion
Takeda Pharmaceutical (NYSE:TAK) $47.6 billion
Vanda Pharmaceuticals (NASDAQ:VNDA) $568.7 million
Vir Biotechnology (NASDAQ:VIR) $3.9 billion
Abbott Labs (NYSE:ABT) $142 billion
Bayer $60.2 billion
Becton Dickinson (NYSE:BDX) $63.2 billion
bioMerieux (OTC:BMXMF) $13.2 billion
Co-Diagnostics (NASDAQ:CODX) $273 million
Danaher (NYSE:DHR) $98.5 billion
Eli Lilly $135.8 billion
Grifols $19.5 billion
LabCorp (NYSE:LH) $11.9 billion
OPKO Health (NASDAQ:OPK) $817.2 million
Quest Diagnostics (NYSE:DGX) $10.4 billion
Roche Holdings $286.7 billion
Thermo Fisher Scientific (NYSE:TMO) $117.7 billion
Arcturus Therapeutics (NASDAQ:ARCT) $249.1 million
BioNTech (NASDAQ:BNTX) $12.2 billion
CSL Behring (OTC:CSLL.Y) $89.8 billion
Dynavax (NASDAQ:DVAX) $293.9 million
GlaxoSmithKline (NYSE:GSK) $93.7 billion
Inovio Pharmaceuticals (NASDAQ:INO) $1.2 billion
Johnson & Johnson (NYSE:JNJ) $357.9 billion
Moderna (NASDAQ:MRNA) $11.4 billion
Novavax (NASDAQ:NVAX) $821.8 million
Pfizer (NYSE:PFE) $190.2 billion
Sanofi (NASDAQ:SNY) $112.9 billion
TranslateBio (NASDAQ:TBIO) $614.1 million
Do you think these companies don't keep an eye on potential competition that has the Holy Cow? What you need is just one that hasn't walked away.
It's not a splitting hairs thing, perhaps it's the defining of certain words. When you say RVA is an offshoot of N-assey not sure how you meant that, the updates you refer too have said it's not the same and novel .
May 18,2020
"This Rapid Viral Assay is a modified ELISA technology that is not the same as our N-Assay modified ELISA."
"We are extremely excited over this technology development, as it is a novel approach in diagnostics"
----
Most would understand misinformation and don't need examples.
Surely you realize that was not an answer.
Perhaps true about Faros, and what ever they have going on is not dead if the stock goes grey. I could make a case that going grey makes sense. The stock trading at par has no value to company anyway
Begs the question. Which came first, the end or going grey?
How is it there is still a barn? They've been grasping at straws ever since the grape juice ran out, why?
"if in fact it works", That's always the question isn't it?
There is no one that has followed the progress of this company who doesn't know that "Nanologix's Technology is at an all time high with past progress advancing present achievements" is a purely fabricated analysis of repeated attempts to advance ideas that went nowhere. I'd ask what progress or achievements you are speaking of but you'd likely have a reply when there clearly is none. In defense of my position, pps .0244 , volume 84,000.
If ,if they would , if they could, if the remaining shares available where sold at the minimum .02 they could possible raise $740g, if the future was so rosy why hasn't that happened, you would think all the progress would entice a new investor to be willing to pay over par. What I'm getting at is there is no advantage for the company to list at .02, really doesn't make a deference to anyone at this point. They either have something or they don't.
If some source. That's always the question when anyone reports using "sources say". Is there even a source? Unreliable BS IMO.
The website that came from is interesting. I suppose you could use the information they provide for various reasons but their stated purpose has nothing to do with stocks.
Good catch, "Sources indicate as part of senior management President and Chief Executive Officer, Bret Barnhizer played a key role in securing the recent investment"
That sentence is void from the beginning, fake news!
Also, being a none reporting company likely puts limits on what they can and can not say. At least they didn't end up on that list that was posted here yesterday.
Maybe it's all the above.
I'm just saying there aren't many brokers that still allow you to buy, it barely trades as it is. If the stock goes even more dark but the company makes something happen, you'll find someone who will buy your shares, or the trading status will change, pretty much where it has been.
I can't explain the silence any better then it explains it's self.
I don't think this has anything to do with what's coming.
Will be a lot like being a private company, in this case at this price the stock really has no value to the company, not sure why NNLX would care if the stock is publicly trading.
So what is it with Therma-Bright, why is it they seem to be progressing just fine while NNLX does nothing? Is Therma Bright a better test, better management, or is it something else?
"The authorizations come two weeks after the FDA created a simple pathway for companies that already had authorized tests to be able to apply to sell an over-the-counter version."
https://www.npr.org/sections/coronavirus-live-updates/2021/04/01/983318237/fda-approves-2-rapid-at-home-covid-tests
Should I buy, sell, hold or pity.
Fortunately I think the problems with PCR are being proven and the benefit of rapid tests excepted. In that environment NNLX has no takers on the offer to partner. With no prototype is there any hope of NNLX showing Big Pharma and others the superiority of their test over the plethora of tests available making similar claims.
Some folks made good money on the pump and dump, probably happy to be on the sidelines. Most of the market is a pump and dump, that is likely the best outcome you could hope for this with stock, only problem is there's nothing to pump.
I agree, they got nothing.
Here's the way I look at this, a simple explanation.
Their tech is no good, all of it. After the flat pack brain storm you have to wonder. None of it works, prove me wrong.
Honestly, Maybe it works, maybe it doesn't, obviously it must not be outstanding, there's a lot of competition who are able to do it on there own.